# EDGAR Filing Document

**Accession Number:** 0001816307
**File Stem:** 0001816307-23-000004
**Filing Date:** 2023-2
**Character Count:** 15273
**Document Hash:** d250c28bd954750c51fa2e63de07d8cb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001816307-23-000004.hdr.sgml**: 20230208

**ACCESSION NUMBER**: 0001816307-23-000004

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230208

**DATE AS OF CHANGE**: 20230207

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Benitec Biopharma Inc.
- **CENTRAL INDEX KEY:** 0001808898
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-91726
- **FILM NUMBER:** 23596277

**BUSINESS ADDRESS:**
- **STREET 1:** 3940 TRUST WAY
- **CITY:** HAYWARD
- **STATE:** CA
- **ZIP:** 94545
- **BUSINESS PHONE:** (510) 780-0819

**MAIL ADDRESS:**
- **STREET 1:** 3940 TRUST WAY
- **CITY:** HAYWARD
- **STATE:** CA
- **ZIP:** 94545
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SILVERARC CAPITAL MANAGEMENT, LLC
- **CENTRAL INDEX KEY:** 0001816307
- **IRS NUMBER:** 834542901
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** 20 PARK PLAZA
- **STREET 2:** 4TH FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116
- **BUSINESS PHONE:** 617.284.6952

**MAIL ADDRESS:**
- **STREET 1:** 20 PARK PLAZA
- **STREET 2:** 4TH FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION<br> Washington, D.C. 20549**

**SCHEDULE 13G**

**Under the Securities Exchange Act of 1934<br> (Amendment No. 1)\***

**Benitec Biopharma Inc.**

(Name of Issuer)

**Common Stock**

(Title of Class of Securities)

**08205P100**

(CUSIP Number)

**December 31, 2022**

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:<br> ☑ Rule 13d-1(b)<br> ☐ Rule 13d-1(c)<br> ☐ Rule 13d-1(d)

<sup>\*</sup> The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 08205P100 13G Page 2 of 10

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;1. | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br>**SilverArc Capital Management, LLC** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br>**SilverArc Capital Management, LLC** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br>**SilverArc Capital Management, LLC** |
| &nbsp;&nbsp;2. | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br> (see instructions)<br> (a) ☐ <br> (b) ☐ | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br> (see instructions)<br> (a) ☐ <br> (b) ☐ | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br> (see instructions)<br> (a) ☐ <br> (b) ☐ |
| &nbsp;&nbsp;3. | &nbsp;&nbsp;SEC USE ONLY | &nbsp;&nbsp;SEC USE ONLY | &nbsp;&nbsp;SEC USE ONLY |
| &nbsp;&nbsp;4. | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>**Delaware** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>**Delaware** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>**Delaware** |
| &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;5. | &nbsp;&nbsp;SOLE VOTING POWER<br>**0** |
| &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;6. | &nbsp;&nbsp;SHARED VOTING POWER<br>**0** |
| &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;7. | &nbsp;&nbsp;SOLE DISPOSITIVE POWER<br>**0** |
| &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;8. | &nbsp;&nbsp;SHARED DISPOSITIVE POWER<br>**0** |
| &nbsp;&nbsp;9. | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON <br>**0** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON <br>**0** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON <br>**0** |
| &nbsp;&nbsp;10. | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br> (see instructions) ☐ | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br> (see instructions) ☐ | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br> (see instructions) ☐ |
| &nbsp;&nbsp;11. | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) <br>**0%** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) <br>**0%** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) <br>**0%** |
| &nbsp;&nbsp;12. | &nbsp;&nbsp;TYPE OF REPORTING PERSON (see instructions) <br>**IA** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (see instructions) <br>**IA** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (see instructions) <br>**IA** |

---

CUSIP No. 08205P100 13G Page 3 of 10

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;1. | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br>**Devesh Gandhi** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br>**Devesh Gandhi** | &nbsp;&nbsp;NAMES OF REPORTING PERSONS<br>**Devesh Gandhi** |
| &nbsp;&nbsp;2. | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br> (see instructions)<br> (a) ☐ <br> (b) ☐ | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br> (see instructions)<br> (a) ☐ <br> (b) ☐ | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br> (see instructions)<br> (a) ☐ <br> (b) ☐ |
| &nbsp;&nbsp;3. | &nbsp;&nbsp;SEC USE ONLY | &nbsp;&nbsp;SEC USE ONLY | &nbsp;&nbsp;SEC USE ONLY |
| &nbsp;&nbsp;4. | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>**United States** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>**United States** | &nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>**United States** |
| &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;5. | &nbsp;&nbsp;SOLE VOTING POWER<br>**0** |
| &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;6. | &nbsp;&nbsp;SHARED VOTING POWER<br>**0** |
| &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;7. | &nbsp;&nbsp;SOLE DISPOSITIVE POWER<br>**0** |
| &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | &nbsp;&nbsp;8. | &nbsp;&nbsp;SHARED DISPOSITIVE POWER<br>**0** |
| &nbsp;&nbsp;9. | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON <br>**0** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON <br>**0** | &nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON <br>**0** |
| &nbsp;&nbsp;10. | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br> (see instructions) ☐ | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br> (see instructions) ☐ | &nbsp;&nbsp;CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br> (see instructions) ☐ |
| &nbsp;&nbsp;11. | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) <br>**0%** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) <br>**0%** | &nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) <br>**0%** |
| &nbsp;&nbsp;12. | &nbsp;&nbsp;TYPE OF REPORTING PERSON (see instructions) <br>**IN** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (see instructions) <br>**IN** | &nbsp;&nbsp;TYPE OF REPORTING PERSON (see instructions) <br>**IN** |

---

CUSIP No. 08205P100 13G Page 4 of 10

**Item 1.**

&nbsp;&nbsp;&nbsp;&nbsp;(a) Name of Issuer

**Benitec Biopharma Inc.**

&nbsp;&nbsp;&nbsp;&nbsp;(b) Address of Issuer's Principal Executive
Offices

**3940 Trust Way, Hayward, California 94545**

**Item 2.**

&nbsp;&nbsp;&nbsp;&nbsp;(a) Name of Person Filing

**SilverArc Capital Management, LLC ("SilverArc") and Devesh Gandhi ("Gandhi" and together with SilverArc, the "Reporting Persons")**

&nbsp;&nbsp;&nbsp;&nbsp;(b) Address of the Principal Office or, if
none, residence

**20 Park Plaza, 4th Floor**

**Boston, MA 02116**

&nbsp;&nbsp;&nbsp;&nbsp;(c) Citizenship

**SilverArc is a Delaware limited liability company. Gandhi is a citizen of the United States.**

&nbsp;&nbsp;&nbsp;&nbsp;(d) Title of Class of Securities

**Common Stock**

&nbsp;&nbsp;&nbsp;&nbsp;(e) CUSIP Number

**08205P100**

CUSIP No. 08205P100 13G Page 5 of 10

**Item 3. If this statement is filed pursuant to Sec. 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

&nbsp;&nbsp;&nbsp;&nbsp;(a) ☐ Broker
or dealer registered under section 15 of the Act (15 U.S.D. 78o):

&nbsp;&nbsp;&nbsp;&nbsp;(b) ☐ Bank
as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

&nbsp;&nbsp;&nbsp;&nbsp;(c) ☐ Insurance
company as de fined in section 3(a)(19) of the Act (15 U.S.C. 78c);

&nbsp;&nbsp;&nbsp;&nbsp;(d) ☐ Investment
company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);

&nbsp;&nbsp;&nbsp;&nbsp;(e) ☑ An
investment adviser in accordance with Sec. 240.13d-1(b)(1)(ii)(E);

&nbsp;&nbsp;&nbsp;&nbsp;(f) ☐ An
employee benefit plan or endowment fund in accordance with Sec. 240.13d-1(b)(1)(ii)(F);

&nbsp;&nbsp;&nbsp;&nbsp;(g) ☑ A
parent holding company or control person in accordance with Sec. 240.13d-1(b)(1)(ii)(G);

&nbsp;&nbsp;&nbsp;&nbsp;(h) ☐ A
savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

&nbsp;&nbsp;&nbsp;&nbsp;(i) ☐ A
church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940
(15 U.S.C. 80a-3);

&nbsp;&nbsp;&nbsp;&nbsp;(j) ☐ A non-U.S.
institution in accordance with Sec. 240.13d-1(b)(1)(ii)(J);

&nbsp;&nbsp;&nbsp;&nbsp;(k) ☐ Group,
in accordance with Sec. 240.13d-1(b)(1)(ii)(J).

**Item 4. Ownership**

This statement is being filed with respect to an aggregate of 0 shares of Common Stock, resulting in beneficial ownership of Common Stock as follows:

1. SilverArc

&nbsp;&nbsp;&nbsp;&nbsp;(a) Amount Beneficially owned: 0.

&nbsp;&nbsp;&nbsp;&nbsp;(b) Percent of Class: 0%.

&nbsp;&nbsp;&nbsp;&nbsp;(c) Number of shares to which the person
has:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Sole power to vote or to direct the vote:
0. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Shared power to vote or to direct the
vote: 0.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Sole power to dispose or to direct the
disposition of: 0.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Shared power to dispose or to direct
the disposition of: 0.

2. Gandhi

&nbsp;&nbsp;&nbsp;&nbsp;(d) Amount Beneficially owned: 0.

&nbsp;&nbsp;&nbsp;&nbsp;(e) Percent of Class: 0%.

&nbsp;&nbsp;&nbsp;&nbsp;(f) Number of shares to which the person
has:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) Sole power to vote or to direct the vote:
0. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) Shared power to vote or to direct the
vote: 0.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) Sole power to dispose or to direct the
disposition of: 0.

CUSIP No. 08205P100 13G Page 6 of 10

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) Shared power to dispose or to direct the disposition of: 587,499.

**Item 5.** **Ownership of Five Percent or Less of a Class.**

---

| | |
|:---|:---|
| ☑ | As of the date of this Report, the aggregate beneficial ownership of the Reporting Persons had been reduced to below five percent (5%). |

---

**Item 6.** **Ownership of More than Five Percent on Behalf of another Person.**

Not Applicable

**Item 7.** **Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.**

Not Applicable

**Item 8.** **Identification and Classification of Members of the Group.**

Not Applicable

**Item 9.** **Notice of Dissolution of Group.**

Not Applicable

CUSIP No. 08205P100 13G Page 7 of 10

**Item 10.** **Certification**

By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

**Exhibits.** 

Exhibit A Joint Filing Agreement by and between the Reporting Persons dated February 07, 2023.

CUSIP No. 08205P100 13G Page 8 of 10

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

---

| | |
|:---|:---|
|  | &nbsp;&nbsp;February 07, 2023 |
|  | &nbsp;&nbsp;Date |
| &nbsp;&nbsp; <br> /s/ Devesh S. Gandhi |  |
| &nbsp;&nbsp;Devesh S. Gandhi, as Sole Member of SilverArc Capital Management, LLC |  |

---

---

| |
|:---|
| &nbsp;&nbsp; <br> /s/ Devesh S. Gandhi |
| &nbsp;&nbsp;Devesh S. Gandhi |

---

CUSIP No. 08205P100 13G Page 9 of 10

**EXHIBIT INDEX**

<u>Ex.</u> <u>Page No.</u> <br>A Joint Filing Agreement 10

CUSIP No. 08205P100 13G Page 10 of 10

**EXHIBIT A**

**JOINT FILING AGREEMENT**

The undersigned hereby agree that the statement on Schedule 13G with respect to the common stock of Benitec Biopharma Inc., dated as of February 07, 2023, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

---

| | |
|:---|:---|
|  | &nbsp;&nbsp;February 07, 2023 |
|  | &nbsp;&nbsp;Date |
| &nbsp;&nbsp; <br> /s/ Devesh S. Gandhi |  |
| &nbsp;&nbsp;Devesh S. Gandhi, as Sole Member of SilverArc Capital Management, LLC |  |

---

---

| |
|:---|
| &nbsp;&nbsp; <br> /s/ Devesh S. Gandhi |
| &nbsp;&nbsp;Devesh S. Gandhi |

---